Word

ALMOND THERAPY: TARGETING THE AMYGDALA

Status

Pending

Status Code

653

Status Date

Tuesday, October 24, 2023

Serial Number

97182740

Mark Type

4000

Filing Date

Tuesday, December 21, 2021

Trademark Owner History

PsiloTec Health Solutions Inc.

Classifications

41 Provision of education in the nature of providing courses of instruction and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education in the nature of providing courses of instruction and training in the field of psychedelic medicines

36 Compilation of medical data for financial purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

35 Compilation for business purposes and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

44 Psychotherapy services; mental health therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services

42 Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing temporary use of online, non-downloadable computer software for providing therapy services in the nature of scheduling and facilitating Internet-based patient and medical provider meetings to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; compilation of medical data for research purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

"THERAPY"

Trademark Events

Oct 24, 2023

Notification Of Letter Of Suspension E-Mailed

Oct 24, 2023

Letter Of Suspension E-Mailed

Oct 24, 2023

Suspension Letter Written

Oct 23, 2023

Teas/Email Correspondence Entered

Oct 23, 2023

Correspondence Received In Law Office

Oct 23, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 22, 2023

Assigned To Lie

May 23, 2023

Teas Response To Suspension Inquiry Received

Feb 23, 2023

Teas Change Of Correspondence Received

Feb 23, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Feb 23, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 23, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 23, 2023

Notification Of Inquiry As To Suspension E-Mailed

Feb 23, 2023

Inquiry To Suspension E-Mailed

Feb 23, 2023

Suspension Inquiry Written

Aug 25, 2022

Notification Of Letter Of Suspension E-Mailed

Aug 25, 2022

Letter Of Suspension E-Mailed

Aug 25, 2022

Suspension Letter Written

Aug 24, 2022

Teas/Email Correspondence Entered

Aug 24, 2022

Correspondence Received In Law Office

Aug 24, 2022

Teas Response To Office Action Received

Jun 28, 2022

Notification Of Non-Final Action E-Mailed

Jun 28, 2022

Non-Final Action E-Mailed

Jun 28, 2022

Non-Final Action Written

Jun 24, 2022

Assigned To Examiner

Dec 28, 2021

New Application Office Supplied Data Entered

Dec 24, 2021

New Application Entered